Use of a genetic cholera toxin B subunit/allergen fusion molecule as mucosal delivery system with immunosuppressive activity against Th2 immune responses.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Vaccine

• Publication date

  2007-12-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2007.10.003PMID 17997199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Specific conformational epitope features of pathogenesis-related proteins mediating cross-reactivity between pollen and food allergens

  2011cited by this paper
• Suppression of diabetes in non-obese diabetic (NOD) mice by oral administration of a cholera toxin B subunit-insulin B chain fusion protein vaccine produced in silkworm.

  2007cited by this paper
• The major allergen from birch tree pollen, Bet v 1, binds and permeabilizes membranes.

  2007cited by this paper
• A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi‐sensitivities

  2007cited by this paper
• The role of Foxp3+ T cells in long‐term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice

  2006cited by this paper
• Immunological mechanisms of allergen-specific immunotherapy

  2006cited by this paper
• Inhibition of Escherichia coli Heat-labile Enterotoxin B Subunit Pentamer (EtxB5) Assembly in Vitro Using Monoclonal Antibodies*

  2006cited by this paper
• Oral Tolerance Induction with Antigen Conjugated to Cholera Toxin B Subunit Generates Both Foxp3+CD25+ and Foxp3−CD25− CD4+ Regulatory T Cells1

  2006cited by this paper
• Mucosal immunity and vaccines

  2005cited by this paper
• Intranasal tolerance induction with polypeptides derived from 3 noncross-reactive major aeroallergens prevents allergic polysensitization in mice.

  2005cited by this paper
• Prophylaxis and therapy of allergy by mucosal tolerance induction with recombinant allergens or allergen constructs.

  2005cited by this paper
• IgE Generation and Mast Cell Effector Function in Mice Deficient in IL-4 and IL-13

  2005cited by this paper
• Induction and recall of immune memory by mucosal immunization with a non‐toxic recombinant enterotoxin‐based chimeric protein

  2005cited by this paper
• Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis *

  2005cited by this paper
• Expression of the B subunit of the heat-labile enterotoxin of Escherichia coli in tobacco mosaic virus-infected Nicotiana benthamiana plants and its characterization as mucosal immunogen and adjuvant.

  2004cited by this paper
• Cholera Toxin and Its B Subunit Promote Dendritic Cell Vaccination with Different Influences on Th1 and Th2 Development

  2003cited by this paper
• T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: predominant role of GATA-3.

  2003cited by this paper
• Analysis of inflammatory gene induction by oxidized phospholipids in vivo by quantitative real-time RT-PCR in comparison with effects of LPS.

  2002cited by this paper
• Total and allergen‐specific immunoglobulin A levels in saliva in relation to the development of allergy in infants up to 2 years of age

  2002cited by this paper
• Cholera Toxin B Subunit as a Carrier Molecule Promotes Antigen Presentation and Increases CD40 and CD86 Expression on Antigen-Presenting Cells

  2001cited by this paper
• Lineage commitment in the immune system: the T helper lymphocyte grows up.

  2000cited by this paper
• Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice.

  2000cited by this paper
• Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy.

  1999cited by this paper
• Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic.

  1999cited by this paper
• Randomized, Double-Blind, Placebo-Controlled, Multicentered Trial of the Efficacy of a Single Dose of Live Oral Cholera Vaccine CVD 103-HgR in Preventing Cholera following Challenge with Vibrio cholerae O1 El Tor Inaba Three Months after Vaccination

  1999cited by this paper
• Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors.

  1999cited by this paper
• Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.

  1999cited by this paper
• A plant-based cholera toxin B subunit–insulin fusion protein protects against the development of autoimmune diabetes

  1998cited by this paper
• Suppression of delayed-type hypersensitivity and IgE antibody responses to ovalbumin by intranasal administration of Escherichia coli heat-labile enterotoxin B subunit-conjugated ovalbumin.

  1997cited by this paper
• SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling

  1997cited by this paper
• A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes.

  1997cited by this paper
• Regulation of IgE responses to inhaled antigen in mice by antigen-specific gamma delta T cells.

  1994cited by this paper
• Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance.

  1994cited by this paper
• Conversion of orally induced suppression of the mucosal immune response to ovalbumin into stimulation by conjugating ovalbumin to cholera toxin or its B subunit.

  1994cited by this paper
• Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems.

  1993cited by this paper
• Intranasal immunization using the B subunit of the Escherichia coli heat‐labile toxin fused to an epitope of the Bordetella pertussis P.69 antigen

  1991cited by this paper
• Cholera toxin B subunit as a carrier protein to stimulate a mucosal immune response.

  1984cited by this paper
• IgA and IgG anti-ragweed antibodies in nasal secretions. Quantitative measurements of antibodies and correlation with inhibition of histamine release.

  1976cited by this paper

• The Role of IgA in Chronic Upper Airway Disease: Friend or Foe?

  2022cites this paper
• Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon

  2020cites this paper
• A recombinant cholera toxin b subunit variant (CTB-KDEL) exhibits unique colon mucosal healing effects that have therapeutic implications for inflammatory bowel disease.

  2019cites this paper
• Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies

  2019cites this paper
• Therapeutic potential of a plant-made cholera toxin b subunit variant for the treatment of ulcerative colitis.

  2018cites this paper
• Murine models for mucosal tolerance in allergy.

  2017cites this paper
• Modulation of the specific immune response in Balb/c mice by intranasal application of recombinant H1D2 chimera

  2017cites this paper
• Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the Mucosa

  2017cites this paper
• The recombinant fusion protein of cholera toxin B and neutrophil-activating protein expressed on Bacillus subtilis spore surface suppresses allergic inflammation in mice

  2017cites this paper
• Allergen immunotherapy for birch pollen-allergic patients: recent advances.

  2016cites this paper
• Recombinant allergens for pollen immunotherapy.

  2013cites this paper
• Regulatory T Cells + Tolerance and Foxp3 Lymphocytes for Mucosal Antigen-Induced RIIB on B g Important Role for Fc

  2013cites this paper
• Potential of Immunoglobulin A to Prevent Allergic Asthma

  2013cites this paper
• Moraxella catarrhalis: from interactions with the host immune system to vaccine development.

  2012cites this paper
• RENATURAÇÃO DE PROTEÍNAS COM ESTRUTURA QUATERNÁRIA

  2012cites this paper
• Induction of immunoglobulin A as a therapeutic intervention in allergic asthma

  2012influential citation
• Factors influencing the allergenicity and adjuvanticity of allergens.

  2011cites this paper
• Effets de différents adjuvants de la famille de la toxine du choléra sur les lymphocytes T CD4 dans un modèle murin d'immunisation intrarectale avec des pseudoparticules virales de rotavirus

  2011cites this paper
• Production of double repeated B subunit of Shiga toxin 2e at high levels in transgenic lettuce plants as vaccine material for porcine edema disease

  2011cites this paper
• Cholera-Like Enterotoxins and Regulatory T cells

  2010cites this paper
• A Genetic Fusion between Sm14 and CTB does not Reduce Schistosoma mansoni Worm Burden on Intranasally Immunized BALB/c Mice

  2010cites this paper
• THE HYGIENE HYPOTHESIS AND MODULATION OF ALLERGY

  2009cites this paper
• Natural Self-Assembly of Allergen-S-Layer Fusion Proteins Is No Prerequisite for Reduced Allergenicity and T Cell Stimulatory Capacity

  2009cites this paper
• Cholera Toxin B and Inactivated in the Presence versus Absence of tularensis Francisella against Mucosal Challenge with Differential Requirements for Protection

  2009cites this paper
• Nasal immunization with heat shock protein 65 attenuates atherosclerosis and reduces serum lipids in cholesterol-fed wild-type rabbits probably through different mechanisms.

  2009cites this paper
• Mucosally induced Immunological Tolerance, Regulatory T Cells and the Adjuvant Effect by Cholera Toxin B Subunit

  2009cites this paper
• Cholera toxin B suppresses allergic inflammation through induction of secretory IgA

  2009cites this paper
• Differential Requirements for Protection against Mucosal Challenge with Francisella tularensis in the Presence versus Absence of Cholera Toxin B and Inactivated F. tularensis 1

  2009cites this paper
• Hitting the mucosal road in tolerance induction.

  2009cites this paper
• Genetic allergen modification in the development of novel approaches to specific immunotherapy

  2009cites this paper
• Efficient induction of oral tolerance by fusing cholera toxin B subunit with allergen-specific T-cell epitopes accumulated in rice seed.

  2008cites this paper
• Lactic acid bacteria as novel adjuvant systems for prevention and treatment of atopic diseases

  2008cites this paper
• Investigation of the Role of Cholera Toxin in Assisting the Initiation of the Antigen-Specific Th2 Response

  2008cites this paper